NYMXF
NYMOX PHARM CORP by Nymox Pharmaceutical Corp. (NYMXF)
$07
About NYMOX PHARM CORP by Nymox Pharmaceutical Corp. (NYMXF)
Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
Details
Daily high
$0.07
Daily low
$0.06
Price at open
$0.07
52 Week High
$0.15
52 Week Low
$0.03
Market cap
4.9M
Dividend yield
0.00%
Volume
102,800
Avg. volume
35,588
P/E ratio
-.54
NYMOX PHARM CORP by Nymox Pharmaceutical Corp. News
Details
Daily high
$0.07
Daily low
$0.06
Price at open
$0.07
52 Week High
$0.15
52 Week Low
$0.03
Market cap
4.9M
Dividend yield
0.00%
Volume
102,800
Avg. volume
35,588
P/E ratio
-.54